UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 74

Sortiert nach

COMPARING THE EPIDEMIOLOGY, COST, AND QUALITY OF LIFE OF RHEUMATOID ARTHRITIS IN CHINA WITH THE REST OF THE WORLD

Value in health, 2016-05, Vol.19 (3), p.A239-A239

2016

Volltextzugriff (PDF)

Assesing the Impact of Patent Loss on Overall Revenues and Stocks Price of Pharmaceutical Companies

Value in health, 2014-11, Vol.17 (7), p.A785-A785

2014

Volltextzugriff (PDF)

Using The Ispor 2013 European Congress as a Big Data Case Study

Value in health, 2014-11, Vol.17 (7), p.A433-A433

2014

Volltextzugriff (PDF)

Comparing the Economic burden of various Diseases from a Payer’s perspective in China

Value in health, 2015-05, Vol.18 (3), p.A295-A296

2015

Volltextzugriff (PDF)

Estimating the Budget Impact of Crizotinib for Alk-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in Argentina

Value in health, 2014-05, Vol.17 (3), p.A74-A74

2014

Volltextzugriff (PDF)

Estimating The Cost-Effectiveness Of Celecoxib For Osteoarthritis In China

Value in health, 2014-05, Vol.17 (3), p.A46-A46

2014

Volltextzugriff (PDF)

ESTIMATING THE COST TO SOCIETY FOR EXENATIDE QW AND INSULIN GLARGINE IN THE UNITED STATES FOR THE TREATMENT OF TYPE 2 DIABETES

Value in health, 2016-05, Vol.19 (3), p.A201-A201

2016

Volltextzugriff (PDF)

Estimating The Societal Costs Associated With Glp-1ras In The United States For The Treatment of Type 2 Diabetes

Value in health, 2016-05, Vol.19 (3), p.A7-A7

2016

Volltextzugriff (PDF)

FRI0242 Disease Burden of Ankylosing Spondylitis in Taiwan: A Population-Based Analysis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.512

2015

Volltextzugriff (PDF)

Estimating The Impact Of Expanding Access To Celecoxib For Osteoarthritis Patients In China

Value in health, 2014-11, Vol.17 (7), p.A772-A772

2014

Volltextzugriff (PDF)

Are the Biotechnology and Pharmaceutical Sectors Defensive Relative to the S&P 500?

Value in health, 2013-11, Vol.16 (7), p.A454-A454

2013

Volltextzugriff (PDF)

EE75 The Economic Value and Learning Curves Associated with Laser Vision Correction

Value in health, 2023-06, Vol.26 (6), p.S73-S73

2023

Volltextzugriff (PDF)

Disease Burden of Psoriatic Arthritis In Taiwan: A Population-Based Analysis

Value in health, 2015-05, Vol.18 (3), p.A158-A158

2015

Volltextzugriff (PDF)

Estimating the burden of illness of painful diabetic peripheral neuropathy in China

Value in health, 2014-05, Vol.17 (3), p.A246-A246

2014

Volltextzugriff (PDF)

Analyzing Investor Preference Towards Bio-Technology Companies In Different Phases

Value in health, 2013-05, Vol.16 (3), p.A263-A263

2013

Volltextzugriff (PDF)

Disease Burden Of Rheumatoid Arthritis In Taiwan: A Population-Based Analysis

Value in health, 2014-05, Vol.17 (3), p.A45-A45

2014

Volltextzugriff (PDF)

Comparing the projected cost per HbA1c reduction of exenatide QW versus liraglutide 1.8 mg for the treatment of type 2 diabetes mellitus using alternate data sources

Value in health, 2014-05, Vol.17 (3), p.A250-A250

2014

Volltextzugriff (PDF)

PMD3 The Current Burden of Cataract Surgery and Outcomes of Image-Guided Systems: A Targeted Literature Review

Value in health, 2021-06, Vol.24, p.S123-S123

2021

Volltextzugriff (PDF)

THU0511 Estimating the Burden of Illness of Fibromyalgia in Taiwan

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A336-A337

2013

Volltextzugriff (PDF)

P08.11.A A subgroup analysis of utilities from European patients using tumor treating fields for glioblastoma

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (Supplement_2), p.ii45-ii45

2022

Volltextzugriff (PDF)

SA7 Outcomes With Novel Therapies for Relapsed or Refractory Follicular Lymphoma: A Targeted Literature Review

Value in health, 2024-06, Vol.27 (6), p.S397-S397

2024

Volltextzugriff (PDF)

EE530 Global Clinical, Economic, Health-Related Quality of Life Burden, and Treatment Outcomes in Follicular Lymphoma: A Systematic Review

Value in health, 2023-12, Vol.26 (12), p.S153-S154

2023

Volltextzugriff (PDF)

DU3 - Why Aren’t You Prescribing My Drug?? Physician Concerns of Biologics for Rheumatoid Arthritis in China

Value in health, 2018-09, Vol.21, p.S5-S5

2018

Volltextzugriff (PDF)

Why Aren’t You Prescribing My Drug?? Physician Concerns of Biologics for Rheumatoid Arthritis in China

Value in health, 2018-09, Vol.21, p.S5

2018

Volltextzugriff (PDF)

PHP2 - Assesing the Impact of Patent Loss on Overall Revenues and Stocks Price of Pharmaceutical Companies

Value in health, 2014-11, Vol.17 (7), p.A785-A785

2014

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(74)

Sprache

Englisch
(74)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

COMPARING THE EPIDEMIOLOGY, COST, AND QUALITY OF LIFE OF RHEUMATOID ARTHRITIS IN CHINA WITH THE REST OF THE WORLD

Assesing the Impact of Patent Loss on Overall Revenues and Stocks Price of Pharmaceutical Companies

Using The Ispor 2013 European Congress as a Big Data Case Study

Comparing the Economic burden of various Diseases from a Payer’s perspective in China

Estimating the Budget Impact of Crizotinib for Alk-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in Argentina

Estimating The Cost-Effectiveness Of Celecoxib For Osteoarthritis In China

ESTIMATING THE COST TO SOCIETY FOR EXENATIDE QW AND INSULIN GLARGINE IN THE UNITED STATES FOR THE TREATMENT OF TYPE 2 DIABETES

Estimating The Societal Costs Associated With Glp-1ras In The United States For The Treatment of Type 2 Diabetes

FRI0242 Disease Burden of Ankylosing Spondylitis in Taiwan: A Population-Based Analysis

Estimating The Impact Of Expanding Access To Celecoxib For Osteoarthritis Patients In China

Are the Biotechnology and Pharmaceutical Sectors Defensive Relative to the S&P 500?

EE75 The Economic Value and Learning Curves Associated with Laser Vision Correction

Disease Burden of Psoriatic Arthritis In Taiwan: A Population-Based Analysis

Estimating the burden of illness of painful diabetic peripheral neuropathy in China

Analyzing Investor Preference Towards Bio-Technology Companies In Different Phases

Disease Burden Of Rheumatoid Arthritis In Taiwan: A Population-Based Analysis

Comparing the projected cost per HbA1c reduction of exenatide QW versus liraglutide 1.8 mg for the treatment of type 2 diabetes mellitus using alternate data sources

PMD3 The Current Burden of Cataract Surgery and Outcomes of Image-Guided Systems: A Targeted Literature Review

THU0511 Estimating the Burden of Illness of Fibromyalgia in Taiwan

P08.11.A A subgroup analysis of utilities from European patients using tumor treating fields for glioblastoma

SA7 Outcomes With Novel Therapies for Relapsed or Refractory Follicular Lymphoma: A Targeted Literature Review

EE530 Global Clinical, Economic, Health-Related Quality of Life Burden, and Treatment Outcomes in Follicular Lymphoma: A Systematic Review

DU3 - Why Aren’t You Prescribing My Drug?? Physician Concerns of Biologics for Rheumatoid Arthritis in China

Why Aren’t You Prescribing My Drug?? Physician Concerns of Biologics for Rheumatoid Arthritis in China

PHP2 - Assesing the Impact of Patent Loss on Overall Revenues and Stocks Price of Pharmaceutical Companies

Suchergebnisse filtern